Program Transfer. If Merck elects to terminate the Research Program as provided in Section 14.1 upon [*], then Merck shall have [*]. If, in addition, in such case Merck desires to [*]. Promptly following Merck’s provision of such notice, [*]. Any such Research Program Development Candidate that [*]. In furtherance of the foregoing, NGM [*]. For clarity, [*].
Appears in 2 contracts
Sources: Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc), Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc)
Program Transfer. If Merck elects to terminate the Research Program as provided in Section 14.1 upon [***], then Merck shall have [***]. If, in addition, in such case Merck desires to [***]. Promptly following Merck’s provision of such notice, [***]. Any such Research Program Development Candidate that [***]. In furtherance of the foregoing, NGM [***]. For clarity, [***].
Appears in 1 contract
Sources: Research Collaboration, Product Development and License Agreement (NGM Biopharmaceuticals Inc)